From: Rett syndrome – biological pathways leading from MECP2 to disorder phenotypes
Changes in RTT
Metabolites
Increased levels [77–79]
Catabolites of catecholamine metabolism, glutamate
Decreased levels [77–80]
Dopamine, norepinephrine (noradrenaline), serotonin, melatonin, myo-inositol, phospholipids, GABA